Cyclodextrins in Pharma Market – Industry Trends and Forecast to 2029
Data Bridge Market Research analyses that the cyclodextrins in pharma market was valued at USD 270.40 million in 2021 and is expected to reach USD 370.06 million by 2029, registering a CAGR of 4.00% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Cyclodextrins are a type of complex cyclic sugar made up of a macrocyclic ring of glucose subunits linked together by alpha-1,4 glycosidic linkages. Cyclodextrin is formed when a starch is decomposed enzymatically into simple molecules. Cyclodextrin is increasingly used in the pharmaceutical and chemical industries as a solvent component in medication delivery. Cyclodextrin is used to increase drug water solubility, stability, and bioavailability by encapsulating hydrophobic medicinal molecules in biological systems.
Browse Related Reports:
https://www.instapaper.com/read/1652123049
https://www.instapaper.com/read/1652123031
https://www.instapaper.com/read/1652123027
https://www.instapaper.com/read/1652123014
https://www.instapaper.com/read/1652123011
https://www.instapaper.com/read/1652871934
https://www.instapaper.com/read/1652871927
https://www.instapaper.com/read/1652871921
https://www.instapaper.com/read/1652871915
https://www.instapaper.com/read/1586514096
https://www.instapaper.com/read/1652870686
https://web.archive.org/save/https://www.databridgemarketresearch.com/reports/global-stroke-market
Comments
Post a Comment